Cognitive function in breast cancer survivors.

作者: Janette Vardy

DOI: 10.1007/978-0-387-75115-3_24

关键词:

摘要: Cancer survivors have coined the terms ‘‘chemobrain’’ and ‘‘chemofog’’ to refer problems that patients experience with their memory and/or concentration during after completing chemotherapy. A number of studies confirmed some breast cancer suffer cognitive impairment chemotherapy [1–8], although recent found women’s may predate [9], hormonal treatment also impact on function [8, 10]. For most women problem appears subtle often improves ceasing chemotherapy; however, for a subset survivors, symptoms are sustained can significantly quality life ability in everyday activities [7, 11, 12]. Cognitive who received inconsistent describing types neuropsychological dysfunction found, commonly affected domains attention/concentration, verbal visual memory, processing speed [1–8, 13]. Similar been identified early stage human immunodeficiency virus (HIV) infection [14, 15], Huntington’s disease [16], Parkinson’s [17] multiple sclerosis [18]. In each these diseases, when occurs, it is generally subtle, ‘‘spotty’’ variable from one patient next 19]. neuropsychologists believe deficits more consistent sub-cortical abnormality 15, 20–23] as distinct cortical seen dementias. Age, intelligence quotient (IQ) education all factors influence [24, 25] corrected standard tests. Other variables affect function, particularly context diagnosis, but difficult correct

参考文章(226)
Fredrick D Ashbury, Helen Findlay, Barbara Reynolds, Krista McKerracher, A Canadian Survey of Cancer Patients’ Experiences: Are Their Needs Being Met? Journal of Pain and Symptom Management. ,vol. 16, pp. 298- 306 ,(1998) , 10.1016/S0885-3924(98)00102-X
M Poppelreuter, J Weis, A.K Külz, O Tucha, K.W Lange, H.H Bartsch, Cognitive dysfunction and subjective complaints of cancer patients. a cross-sectional study in a cancer rehabilitation centre European Journal of Cancer. ,vol. 40, pp. 43- 49 ,(2004) , 10.1016/J.EJCA.2003.08.001
Meyers Ca, Neurocognitive dysfunction in cancer patients. Oncology. ,vol. 14, pp. 75- ,(2000)
Andrew J Saykin, Tim A Ahles, Brenna C McDonald, Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Seminars in Clinical Neuropsychiatry. ,vol. 8, pp. 201- 216 ,(2003)
Catherine M Bender, Karen K Paraska, Susan M Sereika, Christopher M Ryan, Sarah L Berga, Cognitive Function and Reproductive Hormones in Adjuvant Therapy for Breast Cancer: A Critical Review Journal of Pain and Symptom Management. ,vol. 21, pp. 407- 424 ,(2001) , 10.1016/S0885-3924(01)00268-8
S. Littman-Powers, D. Wyld, B. J. Kelly, K. A. McFarland, L. Troy, E. T. Walpole, D. Thomson, Cisplatin-based therapy: A neurological and neurophysical review Psychooncology. ,vol. 9, pp. 29- 39 ,(2000) , 10.1002/(SICI)1099-1611(200001/02)9:1
Christina A. Meyers, Mood and cognitive disorders in cancer patients receiving cytokine therapy. Advances in Experimental Medicine and Biology. ,vol. 461, pp. 75- 81 ,(1999) , 10.1007/978-0-585-37970-8_5